Business Overview and Operational Metrics

Company Foundation: Founded in March 2015 by Dr. Manika Khanna and Dr. Peeyush Khanna.

Network Presence: 8 Hubs + 28 Spokes across 9 states in India.

Clinical Volume: 367 Oocyte Pick-Up (OPU) procedures mentioned.

Financial Metric: Average Revenue Per Patient: ₹3.5 lakhs.

Success Rates: First Attempt success rate of 62%; Multiple Attempts success rate of 85%.

Global Reach: Successfully treated patients from 30+ countries.

AI Initiatives and Clinical Capabilities

AI Tools: Deployment of SiD and ERICA AI tools for embryology and IVF processes, stated as making Gaudium among the few IVF providers in India to deploy both. Early results indicate an 8-9% increase in success rates with these tools.

Key Highlights: SOP-driven organization, state-of-the-art signature laboratories, in-house trained talent (clinicians and embryologists), MANTRANA emotional counselling support, and strict adherence to the ART (Regulation) Act.

Infrastructure: Clinical facilities include consultation rooms, andrology lab, embryology lab, and surgical suite. Specialized equipment includes incubators, laminar flow hoods, centrifuge, and cryo storage tanks.

Expansion Strategy and Growth Plans

FY27 Plan: Launch of 8 new centers.

FY28 Plan: Launch of 1 new center.

Strategic Intent: The expansion is expected to enhance pan-India brand visibility, drive higher customer footfall, increase revenues, strengthen key financial parameters, and position Gaudium among the leading large players in the industry.

Q1 FY27 Financial Performance (Standalone)

Revenue from Operations: ₹1,368.24 lakhs

EBITDA: ₹375.16 lakhs (27.42% margin)

Adjusted EBITDA: ₹507.75 lakhs (37.12% margin)

Profit Before Tax (PBT): ₹253.47 lakhs

Profit After Tax (PAT): ₹193.84 lakhs

Management Commentary on Standalone Performance: The moderation in EBITDA reflects conscious front-loading of expansion-related costs, including pre-operationalization spends at Delhi South Extension Hub, preparatory expenses for upcoming Nagpur and Gurgaon hubs, incremental clinical talent hiring, and integration of AI-led embryology tools (SiD and ERICA). These are characterized as investments made ahead of associated revenue, consistent with the company's planned rollout for FY27.

Q1 FY27 Financial Performance (Consolidated)

Revenue from Operations: ₹1,938.21 lakhs

EBITDA: ₹386.59 lakhs (19.95% margin)

Adjusted EBITDA: ₹532.75 lakhs (27.49% margin)

Profit Before Tax (PBT): ₹238.59 lakhs

Profit After Tax (PAT): ₹181.82 lakhs

Management Commentary on Consolidated Performance: The moderation was driven by expansion-related costs in the IVF business, including new hub setup, clinical hiring, and AI-led embryology investments, which are expected to support growth as new centres scale up.

Shareholding and Market Data (As of June 2026)

NSE Symbol: GAUDIUMIVF

Number of Shares Outstanding: 7,27,86,884

Share Price (BSE as on June 30, 2026): ₹112.95

Market Capitalization: ₹822.13 crore

Industry Classification: Healthcare Service Provider

Corporate Governance

Board of Directors:

  • Dr. Manika Khanna (Promoter & CMD) - MBBS (Gold Medallist), MD in Obstetrics & Gynecology, 16+ years experience in IVF.
  • Dr. Peeyush Khanna (Promoter & WTD) - MBBS, Diploma in Child Health, leads Pediatric Division, 10+ years experience.
  • Mr. Vishad Khanna (Director)
  • Mr. Rajesh C. Bhojani (Independent Director)
  • Mr. Brajesh S Bhadauria (Independent Director)
  • Mr. Suresh Marpu (Independent Director)

Key Personnel:

  • Naveen Kumar (Company Secretary and Compliance Officer)
  • Rakesh Kumar Sharma (CFO)

Awards, Recognitions, and CSR

Notable Awards: India's No. 1 IVF Clinic ranking per Times of India Health Survey, European Quality Award, and several others between 2013-2021.

CSR Initiative - Ladli Shiksha & Swasthya: Focused on empowering adolescent girls from underserved communities. Covers 4 government schools, targets the 11-18 years age group. Key interventions include Education Access (school stationery kits), Health & Menstrual Hygiene Awareness workshops, Health Literacy & SRH Education, and Life Skills & Leadership Development.

Forward-Looking Statements Disclaimer

The document contains forward-looking statements identified by words such as \"aim,\" \"anticipate,\" \"believe,\" \"expect,\" etc. The company cautioned that actual results could differ materially from these statements and advised investors not to place undue reliance on them.